Jakarta's Latest Official COVID-19 Figures as of April 15

The Jakarta COVID-19 Quick Handling Task Force announces the latest information of Coronavirus Disease 2019 (COVID-19) cases as of April 15.

The number of people tested last week has reached 68,306

Jakarta Health Agency's Disease Prevention and Control Division Head Dwi Oktavia Tatri Lestari stated, based on the latest data, the swab tests had been carried out on 12,268 specimens. 10,673 of them were to diagnose new cases with 1,330 positive and 9,343 negative results. In addition, an antigen test was also held today, where 3,261were tested, with 66 positive results and 3,195 negative results.

"The number of people tested last week has reached 68,306, while 337,060 people have undergone the swab tests. As for the number of active cases in Jakarta to date was 6,988 people who were undergoing self-isolation at home (including data of athlete's homestead) or decreased to 789 cases," she expressed, as quoted by Jakarta's PPID press release, Thursday (4/15).

Latest Information on COVID-19 Cases and Vaccination in Jakarta as of April 14, 2021

As for the total number of confirmation cases in Jakarta to date was 396,109 cases. Of these cases, 382,617 people were cured with a cure rate reaching 96.6% and 6,504 people died with a world with a death rate of 1.6%, while Indonesia's death rate was 2.7%. The positivity rate in the last week in Jakarta was 9.6%, while Indonesia was 11%. WHO also set a standard percentage of positive cases of no more than 5%.

Meanwhile, the vaccination process was still ongoing. The number of vaccination targets for stages 1 and 2 (health workers, the elderly, and public servants) was 3,000,689 people. The total vaccination dose 1 was currently 1,598,341 people (53.3%) and the total vaccination dose 2 now reached 783,181people (26.1%).

With the detailed, vaccination dose 1 for health workers reached 124,484 people (110.8%) and vaccination dose 2 included 108,418 people (96.5%), with a vaccination target of 112.301 people. As for the elderly, vaccination dose 1 was done to 543,256 people (59.6%) and vaccination dose 2 included 231,255 people (25.4%), with a vaccination target of 911,631 people. In the public service, vaccination dose 1 was administered to 930,601  people (47.1%) and vaccination dose 2 included 443,508people (22.4%), with a vaccination target of 1,976,757 people.

Amid PSBB, residents wanting to enter the Jakarta area were urged to carry out independent COVID-19 check-up through the JakCLM via JAKI app. In this app, they could find out the risk of COVID-19 and got various health recommendations according to the risks they have. This contribution would help the government to prevent the diseases in Jakarta.

Together with Satpol PP, the operation for residents who do not wear masks will also be intensified, including other PSBB violations. Hopefully, they can be more disciplined in implementing health protocols and participating in stopping the chain of COVID-19.

Here is the recap data of violations and prosecution compiled by Satpol PP in tightening the PSBB as of April 14 at 6 PM, as follows:

A. Masks

- Social Work = 1,691

- Fine = 14

Total = 1,705

B. Restaurant

- Fine = 0

- Temporary suspension of activities for 1x24 = 4

- Temporary suspension of activities for 3x24 = 0

- Written warning = 15

- Disbandment = 1

- License Revocation = 0

- Zero violation = 223

- Total = 243

C. Workplaces, Business Places, Industrial Places

- Fine = 0

- Temporary suspension of activities for 3x24 hours = 1

- Written warning = 22

- License Revocation = 0

- Zero violation = 287

- Total = 310

D. Value of Fines

- Individual = Rp 1,250,000

- Place of business to eat and drink/restaurant = Rp 0

- Workplace/Industrial = Rp 0

- Amount = Rp 1,250,000

As for the information, the community also has the opportunity to donate with others in the large-scale social collaboration (KSBB) program. They can provide aid in the form of staple foods, fast food and cash. For further information, please visit corona.jakarta.go.id/kolaborasi.